# Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control

> **NCT01066039** · PHASE4 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 202 (actual)

## Conditions studied

- Hypertension
- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Bisoprolol

## Key facts

- **NCT ID:** NCT01066039
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2014-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066039, "Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT01066039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*